Because the CAFC demonstrated a primitive immunophenotype and increased self-renewal capacity compared to cells in suspension, we next wanted to determine whether the CD19−CD133+ cells have a decreased proliferation rate compared to the CD19+CD133− MCL cells. This evidence concerns the gene PROM1 and mantle cell lymphoma.